Ethynodiol Diacetate And Ethinyl Estradiol Kit
Product Images NDC 0378-7307

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ethynodiol Diacetate And Ethinyl Estradiol (NDC 0378-7307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (E76714c0 97e3 4030 Baba 0b4caf86ac34 01)

The text contains chemical names and formulas for two substances: ethynodiol diacetate and ethinyl estradiol. The molecular weight for ethynodiol diacetate is 384.51 and for ethinyl estradiol, it is 206.41. It is likely a document related to chemistry or pharmacology.*

FDA Label Image

Graph (E76714c0 97e3 4030 Baba 0b4caf86ac34 02)

This appears to be a table or graph showing mortality rates based on the number of deaths per 100,000 woman-years, categorized by age group and smoking habits. Unfortunately, the content of the table is not fully readable from the text provided.*

FDA Label Image

Blister (E76714c0 97e3 4030 Baba 0b4caf86ac34 03)

This is a description of a prescription drug, NDC 0378-7307-85, containing Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP, 1 mg/35 mcg, packaged in a container with 28 tablets. It is to be stored at a temperature range of 20° to 25°C (68° to 77°F). The tablets are light orange in color and the prescription is marked for use only under healthcare provider advice. The days of the week SUN, MON, TUE, and FRI are listed, possibly indicating a dosing schedule for the medication.*

FDA Label Image

Image 01

This is a description of a birth control pill called Ethynodiol Diacetate and Ethinyl Estradiol Tablets, USP made by Mylon Pharmaceuticals Inc. This pill is intended to prevent pregnancy and protect against HIV and other sexually transmitted diseases. Each pouch contains 3 packs of 25 tablets. The usual dosage is taken for 21 days with a break of 7 days before resuming. The packaging mentions a patented seal to ensure tamper-proofing. The medication should be stored at controlled room temperature and kept out of reach of children.*

FDA Label Image

Image 03

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.